Thursday, 29 September 2016

MetroGel


Generic Name: metronidazole topical (MET roe NYE da zole)

Brand Names: MetroCream, MetroGel, MetroLotion, Noritate


What is MetroGel (metronidazole topical)?

Metronidazole is an antibiotic that fights bacteria in the body.


Metronidazole topical (for the skin) is used to treat skin lesions caused by rosacea.


Metronidazole topical may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about MetroGel (metronidazole topical)?


Do not use metronidazole topical if you have ever had an allergic reaction to it.


Before using metronidazole topical, tell your doctor if you are allergic to any drugs, or if you have a blood cell disorder such as anemia or decreased white blood cells.


Tell your doctor about all other medications you use, especially a blood thinner such as warfarin (Coumadin).


Metronidazole topical is for use only on the skin. Avoid getting this medication in your eyes. If this does happen, rinse thoroughly with cool water. Do not use topical metronidazole in the vagina. Call your doctor if you have severe stinging or burning when you apply metronidazole topical. Use this medication for the entire length of time prescribed by your doctor. Your symptoms may get better before any infection is completely treated. Do not use metronidazole topical to treat any other skin infection your doctor has not prescribed it for.

What should I discuss with my doctor before using MetroGel (metronidazole topical)?


Do not use metronidazole topical if you have ever had an allergic reaction to it.


Before using metronidazole topical, tell your doctor if you are allergic to any drugs, or if you have a blood cell disorder such as anemia or decreased white blood cells.


If you have any of these conditions, you may need a dose adjustment or special tests to safely use metronidazole topical.


FDA pregnancy category B. This medication is not expected to be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. Metronidazole passes into breast milk and could harm a nursing infant. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How should I use MetroGel (metronidazole topical)?


Use this medication exactly as it was prescribed for you. Do not use the medication in larger amounts, or use it for longer than recommended by your doctor.


Wash and gently dry your skin before applying metronidazole topical

Apply the medication in a thin layer and rub in completely. You may apply cosmetics after using metronidazole topical.


Use this medication for the entire length of time prescribed by your doctor. Your symptoms may get better before any infection is completely treated. Do not use metronidazole topical to treat any other skin infection your doctor has not prescribed it for. Store metronidazole topical at room temperature away from moisture or heat.

What happens if I miss a dose?


Use the medication as soon as you remember. If it is almost time for the next dose, skip the missed dose and use the medicine at the next regularly scheduled time. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine.

An overdose of metronidazole applied to the skin is not expected to produce life-threatening symptoms.


What should I avoid while using MetroGel (metronidazole topical)?


Metronidazole topical is for use only on the skin. Avoid getting this medication in your eyes. If this does happen, rinse thoroughly with cool water. Do not use topical metronidazole in the vagina.

MetroGel (metronidazole topical) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Call your doctor if you have severe stinging or burning when you apply metronidazole topical.

Less serious side effects may include:



  • mild burning or stinging when the medication is applied;




  • numbness or tingly feeling in your hands or feet;




  • cough, stuffy nose, sore throat, cold symptoms;




  • vaginal itching or discharge;




  • headache;




  • dry, scaly, or itchy skin;




  • nausea; or




  • metallic taste in your mouth.



This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect MetroGel (metronidazole topical)?


Tell your doctor about all other medications you use, especially a blood thinner such as warfarin (Coumadin).


It is not likely that other drugs you take orally or inject will have an effect on topically applied metronidazole. But many drugs can interact with each other. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More MetroGel resources


  • MetroGel Side Effects (in more detail)
  • MetroGel Use in Pregnancy & Breastfeeding
  • MetroGel Drug Interactions
  • MetroGel Support Group
  • 6 Reviews for MetroGel - Add your own review/rating


  • MetroGel Cream MedFacts Consumer Leaflet (Wolters Kluwer)

  • MetroGel Prescribing Information (FDA)

  • MetroCream Prescribing Information (FDA)

  • Metrocream

  • Metrogel Topical Advanced Consumer (Micromedex) - Includes Dosage Information

  • Metrogel-Vaginal Advanced Consumer (Micromedex) - Includes Dosage Information

  • Metrolotion

  • Noritate Prescribing Information (FDA)

  • Rozex Emulsion MedFacts Consumer Leaflet (Wolters Kluwer)

  • Vandazole Prescribing Information (FDA)

  • Vitazol Prescribing Information (FDA)



Compare MetroGel with other medications


  • Perioral Dermatitis
  • Rosacea


Where can I get more information?


  • Your pharmacist can provide more information about metronidazole topical.

See also: MetroGel side effects (in more detail)


Erymax


Generic Name: erythromycin topical (ee RITH roe MYE sin)

Brand Names: A/T/S, Akne-Mycin, Emcin Clear, Emgel, Eryderm, Erygel, Erymax, Romycin, Theramycin Z


What is Erymax (erythromycin topical)?

Erythromycin topical is an antibiotic that fights skin infection caused by bacteria.


Erythromycin topical (for the skin) is used to treat bacterial infections such as severe acne.


Erythromycin topical may also be used for purposes not listed in this medication guide.


What is the most important information I should know about Erymax (erythromycin topical)?


Use exactly as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.


Wash your hands before and after using this medicine.

Avoid using other medications on the areas you treat with erythromycin topical unless you doctor tells you to.


Avoid getting this medication in your eyes, mouth, and nose, or on your lips. If it does get into any of these areas, rinse with water. It may take up to 12 weeks before your symptoms improve. Keep using the medication as directed and tell your doctor if your symptoms do not improve after 6 weeks of treatment.

Antibiotic medicines can cause diarrhea, which may be a sign of a new infection. If you have diarrhea that is watery or bloody, stop taking erythromycin topical and call your doctor. Do not use anti-diarrhea medicine unless your doctor tells you to.


What should I discuss with my healthcare provider before using Erymax (erythromycin topical)?


You should not use erythromycin topical if you are allergic to it. FDA pregnancy category C. It is not known whether erythromycin topical will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication. Erythromycin topical can pass into breast milk and may harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. Do not use this medicine on a child younger than 18 years old without the advice of a doctor.

How should I use Erymax (erythromycin topical)?


Use exactly as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.


Do not use erythromycin topical to treat any skin condition that has not been checked by your doctor. Wash your hands before and after using this medicine.

Clean and dry the skin area before you apply erythromycin topical. Spread the medicine on lightly, without rubbing it in.


Erythromycin topical is usually applied once or twice daily. Follow your doctor's instructions.


It may take up to 12 weeks before your symptoms improve. Keep using the medication as directed and tell your doctor if your symptoms do not improve after 6 weeks of treatment. Store at room temperature away from moisture and heat. Keep the tube or bottle tightly closed when not in use.

The gel form of this medicine is flammable. Do not use near high heat or open flame.


What happens if I miss a dose?


Use the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while taking Erymax (erythromycin topical)?


Avoid using other medications on the areas you treat with erythromycin topical unless you doctor tells you to.


Avoid using skin products that can cause irritation, such as harsh soaps or skin cleansers, or skin products with alcohol, spices, astringents, or lime.


Avoid getting this medication in your eyes, mouth, and nose, or on your lips. If it does get into any of these areas, rinse with water.

Antibiotic medicines can cause diarrhea, which may be a sign of a new infection. If you have diarrhea that is watery or bloody, stop taking erythromycin topical and call your doctor. Do not use anti-diarrhea medicine unless your doctor tells you to.


Erymax (erythromycin topical) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using erythromycin topical and call your doctor at once if you have any of these serious side effects:

  • severe burning, stinging, or redness;




  • oozing or other signs of skin infection;




  • worsening of your skin condition; or




  • diarrhea that is watery or bloody.



Less serious side effects may include:



  • mild skin irritation or tenderness;




  • dry or oily skin;




  • itching;




  • peeling; or




  • mild eye irritation.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Erymax (erythromycin topical)?


It is not likely that other drugs you take orally or inject will have an effect on topically applied erythromycin. But many drugs can interact with each other. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Erymax resources


  • Erymax Side Effects (in more detail)
  • Erymax Use in Pregnancy & Breastfeeding
  • Erymax Support Group
  • 0 Reviews for Erymax - Add your own review/rating


  • A/T/S Topical Advanced Consumer (Micromedex) - Includes Dosage Information

  • Akne-Mycin Ointment MedFacts Consumer Leaflet (Wolters Kluwer)

  • Emcin Clear Pad MedFacts Consumer Leaflet (Wolters Kluwer)

  • Emgel Gel MedFacts Consumer Leaflet (Wolters Kluwer)

  • Ery Pads Prescribing Information (FDA)

  • Eryderm Solution MedFacts Consumer Leaflet (Wolters Kluwer)

  • Erygel Prescribing Information (FDA)

  • Erythra-Derm Prescribing Information (FDA)

  • Romycin Advanced Consumer (Micromedex) - Includes Dosage Information

  • Romycin eent Monograph (AHFS DI)

  • Romycin Ointment MedFacts Consumer Leaflet (Wolters Kluwer)

  • Staticin Prescribing Information (FDA)

  • T-Stat Prescribing Information (FDA)



Compare Erymax with other medications


  • Acne
  • Perioral Dermatitis


Where can I get more information?


  • Your pharmacist can provide more information about erythromycin topical.

See also: Erymax side effects (in more detail)


Wednesday, 28 September 2016

Mioblock




Mioblock may be available in the countries listed below.


Ingredient matches for Mioblock



Pancuronium

Pancuronium Bromide is reported as an ingredient of Mioblock in the following countries:


  • Japan

International Drug Name Search

fosamprenavir


fos-am-PREN-a-vir


Commonly used brand name(s)

In the U.S.


  • Lexiva

Available Dosage Forms:


  • Tablet

  • Suspension

Therapeutic Class: Antiretroviral Agent


Pharmacologic Class: Protease Inhibitor


Uses For fosamprenavir


Fosamprenavir is used in combination with other medicines to treat patients who are infected with the human immunodeficiency virus (HIV). HIV is the virus that causes acquired immune deficiency syndrome (AIDS).


Fosamprenavir may slow down the destruction of the immune system caused by HIV. This may help delay problems that are usually related to AIDS or HIV disease from occurring. However, fosamprenavir will not cure or prevent HIV infection, and it will not keep you from spreading the virus to other people. Patients who receive fosamprenavir may continue to have other problems usually related to AIDS or HIV disease.


fosamprenavir is available only with your doctor's prescription.


Before Using fosamprenavir


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For fosamprenavir, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to fosamprenavir or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of fosamprenavir in children younger than 2 years of age. Safety and efficacy have not been established.


Geriatric


Although appropriate studies on the relationship of age to the effects of fosamprenavir have not been performed in the geriatric population, geriatric-specific problems are not expected to limit the usefulness of fosamprenavir in the elderly. However, elderly patients are more likely to have age-related liver, kidney, or heart problems, which may require caution and an adjustment in the dose for patients receiving fosamprenavir.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking fosamprenavir, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using fosamprenavir with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Alfuzosin

  • Cisapride

  • Delavirdine

  • Dihydroergotamine

  • Ergoloid Mesylates

  • Ergonovine

  • Ergotamine

  • Lovastatin

  • Methylergonovine

  • Midazolam

  • Pimozide

  • Ranolazine

  • Rifampin

  • Sildenafil

  • Simvastatin

  • St John's Wort

  • Triazolam

Using fosamprenavir with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Amiodarone

  • Atazanavir

  • Bepridil

  • Bosentan

  • Colchicine

  • Crizotinib

  • Dexamethasone

  • Efavirenz

  • Etravirine

  • Everolimus

  • Fentanyl

  • Garlic

  • Ixabepilone

  • Lidocaine

  • Nevirapine

  • Quinidine

  • Raltegravir

  • Rifabutin

  • Rifapentine

  • Rosuvastatin

  • Salmeterol

  • Saquinavir

  • Telaprevir

  • Tipranavir

  • Tolvaptan

Using fosamprenavir with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Atorvastatin

  • Cyclosporine

  • Desogestrel

  • Dienogest

  • Drospirenone

  • Estradiol Cypionate

  • Estradiol Valerate

  • Ethinyl Estradiol

  • Ethynodiol Diacetate

  • Etonogestrel

  • Fosphenytoin

  • Ketoconazole

  • Levonorgestrel

  • Lopinavir

  • Medroxyprogesterone Acetate

  • Mestranol

  • Methadone

  • Norelgestromin

  • Norethindrone

  • Norgestimate

  • Norgestrel

  • Paroxetine

  • Phenytoin

  • Ranitidine

  • Ritonavir

  • Voriconazole

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of fosamprenavir. Make sure you tell your doctor if you have any other medical problems, especially:


  • Anemia, hemolytic or

  • Cholesterol problem (high fat in the blood) or

  • Diabetes or

  • Hemophilia (a bleeding problem) or

  • Hyperglycemia (high blood sugar) or

  • Kidney problems (e.g., kidney stones)—Use with caution. May make these conditions worse.

  • Hepatitis B or

  • Hepatitis C or

  • Liver disease or

  • Sulfa allergy, history of—Use with caution. May cause side effects to become worse.

Proper Use of fosamprenavir


Take fosamprenavir exactly as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered. Also, do not stop taking fosamprenavir without first checking with your doctor. When your supply of fosamprenavir is running low, contact your doctor or pharmacist ahead of time. Do not allow yourself to run out of fosamprenavir.


fosamprenavir comes with a patient information insert. Read and follow the instructions in the insert carefully. Ask your doctor if you have any questions.


Fosamprenavir suspension should be taken by adults without food. Children should take the oral suspension with food.


Shake the oral suspension well before each use. Use a marked measuring spoon, oral syringe, or medicine cup to measure the dose. The average household teaspoon may not hold the right amount of liquid.


Fosamprenavir tablets may be taken with or without food. However, it should not be taken with a high-fat meal. Taking fosamprenavir with a high-fat meal may decrease the amount of fosamprenavir that is absorbed by the body and prevent the medicine from working properly.


It is important to take fosamprenavir as part of a combination treatment. Your dose of medicine will be based on what other medicines you are taking, as well as your weight. Be sure to take all the medicines your doctor has prescribed for you, including fosamprenavir.


Keep taking fosamprenavir for the full time of treatment, even if you begin to feel better.


fosamprenavir works best when there is a constant amount in the blood. To help keep the amount constant, do not miss any doses. Also, it is best to take the doses at evenly spaced times, day and night. For example, if you are to take two doses a day, the doses should be spaced about 12 hours apart. If you need help in planning the best times to take your medicine, check with your doctor.


Only take medicine that your doctor has prescribed especially for you. Do not share your medicine with others.


If you miss a dose or forget to use your medicine, use it as soon as you can. If your next regular dose is more than 4 hours away, wait until then to use the medicine and skip the missed dose.


Dosing


The dose of fosamprenavir will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of fosamprenavir. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage forms (suspension or tablets):
    • For treatment of HIV infection:
      • Adults who have not taken HIV medicines called protease inhibitors in the past (fosamprenavir alone)—1400 milligrams (mg) (2 tablets) two times a day.

      • Adults who have not taken HIV medicines called protease inhibitors in the past (fosamprenavir together with ritonavir)—1400 mg (2 tablets) fosamprenavir with 200 mg ritonavir one time per day or 1400 mg (2 tablets) fosamprenavir with 100 mg ritonavir one time per day or 700 mg fosamprenavir with 100 mg ritonavir two times a day.

      • Adults who have taken HIV medicines called protease inhibitors in the past (fosamprenavir together with ritonavir)—700 mg fosamprenavir with 100 mg ritonavir two times a day. Adults who have taken HIV medicines called protease inhibitors in the past should not take the combination of fosamprenavir with ritonavir only one time a day. Check with your doctor if you are unsure of what amounts and how many times a day you should be taking your medicines. If you are taking fosamprenavir with ritonavir and efavirenz, check with your doctor for the correct doses.

      • Children 6 years of age and older who have not taken HIV medicines called protease inhibitors in the past (fosamprenavir alone)—Dose is based on body weight and must be determined by your doctor. The usual suspension dose is 30 milligrams (mg) per kilogram (kg) of body weight two times a day.

      • Children 6 years of age and older who have not taken HIV medicines called protease inhibitors in the past (fosamprenavir together with ritonavir)—Dose is based on body weight and must be determined by your doctor. The usual suspension dose is fosamprenavir 18 mg per kg of body weight with ritonavir 3 mg per kg of body weight two times a day.

      • Children 6 years of age and older who have taken HIV medicines called protease inhibitors in the past (fosamprenavir alone) and weigh 47 kg or more—1400 mg (2 tablets) two times a day.

      • Children 6 years of age and older who have taken HIV medicines called protease inhibitors in the past (fosamprenavir together with ritonavir)—Dose is based on body weight and must be determined by your doctor. The usual suspension dose is fosamprenavir 18 mg per kg of body weight with ritonavir 3 mg per kg of body weight two times a day.

      • Children 2 to 5 years of age who have not taken HIV medicines called protease inhibitors in the past (fosamprenavir alone)—Dose is based on body weight and must be determined by your doctor. The usual suspension dose is 30 mg per kg of body weight two times a day.

      • Children younger than 2 years of age—Use and dose must be determined by your doctor.



Missed Dose


If you miss a dose of fosamprenavir, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


If you or your child vomits 30 minutes after the first dose, a second dose should be taken right away.


Storage


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


The oral suspension may also be refrigerated. Do not freeze.


Precautions While Using fosamprenavir


It is very important that your doctor check the progress of you or your child at regular visits to make sure fosamprenavir is working properly. Blood tests may be needed to check for unwanted effects.


Do not use fosamprenavir if you or your child are also using alfuzosin (Uroxatral®), cisapride (Propulsid®), delavirdine (Rescriptor®), flecainide (Tambocor®), lovastatin (Altocor®, Mevacor®), oral midazolam (Versed®), pimozide (Orap®), propafenone (Rythmol®), rifampin (Rifadin®, Rimactane®), salmeterol (Advair®, Serevent®), sildenafil (Revatio®), simvastatin (Simcor®, Vytorin®, Zocor®), triazolam (Halcion®), or ergot medicines (e.g., dihydroergotamine, ergonovine, ergotamine, methylergonovine, Cafergot®, D.H.E. 45®, Ergomar®, Ergostat®, Ergotrate®, Methergine®, Migranal®, or Wigraine®).


Do not take other medicines unless they have been discussed with your doctor. This includes prescription and nonprescription (over-the-counter [OTC]) medicines, and herbal (e.g., St. John's wort) or vitamin supplements.


When you start taking HIV medicines, your immune system may get stronger. If you have infections that are hidden in your body, such as pneumonia or tuberculosis, you or your child may notice new symptoms when your body tries to fight them. If this occurs, tell your doctor immediately.


Tell your doctor if you are also taking sildenafil (Viagra®), tadalafil (Cialis®), or vardenafil (Levitra®). Taking these medicines together with fosamprenavir may increase your risk of having side effects such as low blood pressure, changes in vision, or prolonged erection of the penis.


Birth control pills may not work as well while you are using fosamprenavir. To keep from getting pregnant, use an additional form of birth control along with your pills. Other forms of birth control include condoms, diaphragms, or contraceptive foams or jellies.


fosamprenavir may increase blood sugar levels. Check with your doctor if you or your child notice a change in the results of your blood or urine sugar tests.


Serious skin reactions can occur with fosamprenavir. Stop using fosamprenavir and check with your doctor right away if you or your child have blistering, peeling, or loosening of the skin; itching; white spots in the mouth or on the lips; or redness of the skin.


Check with your doctor right away if you or your child have any of the following symptoms while using fosamprenavir: itching; skin rash; or swelling of the face, lips, and tongue. You may be having a serious skin reaction or a condition called angioedema.


fosamprenavir may cause you to have excess body fat. Tell your doctor if you or your child notice changes in your body shape, such as an increased amount of fat in the upper back and neck, or around the chest and stomach area. You might also lose fat from the legs, arms, and face.


fosamprenavir may increase your cholesterol and fats in the blood. If this condition occurs, your doctor may give you or your child some medicines that can lower the amount of cholesterol and fats in the blood.


fosamprenavir may increase your risk of having kidney stones. Check with your doctor right away and stop using fosamprenavir if you or your child have blood in your urine, nausea and vomiting, pain in the groin or genitals, or sharp back pain just below the ribs.


Fosamprenavir does not decrease the risk of transmitting the HIV infection to others through sexual contact or by contamination through blood. HIV may be acquired from or spread to others through infected body fluids, including blood, vaginal fluid, or semen. If you are infected, it is best to avoid any sexual activity involving an exchange of body fluids with other people. If you do have sex, always wear (or have your partner wear) a condom (“rubber”). Only use condoms made of latex, and use them every time you have vaginal, anal, or oral sex. The use of a spermicide (such as nonoxynol-9) may also help prevent the spread of HIV if it is not irritating to the vagina, rectum, or mouth. Spermicides have been shown to kill HIV in lab tests. Do not use oil-based jelly, cold cream, baby oil, or shortening as a lubricant—these products can cause the condom to break. Lubricants without oil, such as K-Y Jelly, are recommended. Women may wish to carry their own condoms. Birth control pills and diaphragms will help protect against pregnancy, but they will not prevent someone from giving or getting the AIDS virus. If you inject drugs, get help to stop. Do not share needles or equipment with anyone. In some cities, more than half of the drug users are infected, and sharing even 1 needle or syringe can spread the virus. If you have any questions about this, check with your doctor.


Tell the doctor in charge that you or your child are taking fosamprenavir before you have any medical tests. The results of some tests may be affected by fosamprenavir.


fosamprenavir Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Large amount of fat in the blood

  • severe skin rash

Less common
  • Abdominal or stomach pain

  • blurred vision

  • depression

  • dry mouth

  • fatigue

  • flushed, dry skin

  • fruit-like breath odor

  • increased hunger

  • increased thirst

  • increased urination

  • mood or mental changes

  • nausea

  • sweating

  • troubled breathing

  • unexplained weight loss

  • vomiting

Rare
  • Back, leg, or stomach pains

  • bleeding gums

  • blistering, peeling, or loosening of the skin

  • chills

  • cough

  • dark urine

  • diarrhea

  • difficulty with breathing

  • fever

  • general body swelling

  • itching

  • joint or muscle pain

  • loss of appetite

  • nosebleeds

  • pale skin

  • red skin lesions often with a purple center

  • red, irritated eyes

  • sore throat

  • sores, ulcers, or white spots in the mouth or on the lips

  • unusual tiredness or weakness

  • yellowing of the eyes or skin

Incidence not known
  • Large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Itching skin

  • mild or moderate rash

Less common
  • Burning or prickling sensation around the mouth

  • headache

Incidence not known
  • Breast enlargement

  • buffalo hump

  • increased fat deposits on the face, neck, and trunk

  • obesity

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: fosamprenavir side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More fosamprenavir resources


  • Fosamprenavir Side Effects (in more detail)
  • Fosamprenavir Use in Pregnancy & Breastfeeding
  • Fosamprenavir Drug Interactions
  • Fosamprenavir Support Group
  • 0 Reviews for Fosamprenavir - Add your own review/rating


  • Fosamprenavir MedFacts Consumer Leaflet (Wolters Kluwer)

  • Fosamprenavir Calcium Monograph (AHFS DI)

  • Lexiva Prescribing Information (FDA)

  • Lexiva Consumer Overview



Compare fosamprenavir with other medications


  • HIV Infection
  • Nonoccupational Exposure

Cyclopentolat Chauvin




Cyclopentolat Chauvin may be available in the countries listed below.


Ingredient matches for Cyclopentolat Chauvin



Cyclopentolate

Cyclopentolate hydrochloride (a derivative of Cyclopentolate) is reported as an ingredient of Cyclopentolat Chauvin in the following countries:


  • Sweden

International Drug Name Search

Exelderm Solution


Pronunciation: sul-KON-a-zole
Generic Name: Sulconazole Nitrate
Brand Name: Exelderm


Exelderm Solution is used for:

Treating fungal infections, such as jock itch, ringworm, and tinea versicolor (a fungal infection affecting the skin of the upper arms, chest, back, and sometimes the neck and face).


Exelderm Solution is an antifungal. It works by blocking the growth of fungi.


Do NOT use Exelderm Solution if:


  • you are allergic to any ingredient in Exelderm Solution

Contact your doctor or health care provider right away if any of these apply to you.



Before using Exelderm Solution:


Some medical conditions may interact with Exelderm Solution. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

Some MEDICINES MAY INTERACT with Exelderm Solution. Because little, if any, of Exelderm Solution is absorbed into the blood, the risk of it interacting with another medicine is low.


This may not be a complete list of all interactions that may occur. Ask your health care provider if Exelderm Solution may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Exelderm Solution:


Use Exelderm Solution as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • To clear up your infection completely, continue using Exelderm Solution for the full course of treatment.

  • Exelderm Solution is for external use only.

  • Clean the affected area with soap and water and dry thoroughly. Apply enough medicine to cover the affected area. Rub in gently.

  • Do not cover unless directed otherwise by your doctor.

  • Wash your hands immediately after using Exelderm Solution, unless your hands are part of the treated area.

  • If you miss a dose of Exelderm Solution, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule.

Ask your health care provider any questions you may have about how to use Exelderm Solution.



Important safety information:


  • Exelderm Solution is for external use only.

  • Do not get Exelderm Solution in your eyes.

  • Exelderm Solution may be harmful if swallowed. If you may have taken Exelderm Solution by mouth, contact your local poison control center or emergency room immediately.

  • Overuse of topical products may worsen your condition.

  • If your condition does not improve within 4 to 6 weeks or if it gets worse, check with your doctor.

  • Use Exelderm Solution with caution in the ELDERLY because they may be more sensitive to its effects.

  • Use Exelderm Solution with extreme caution in CHILDREN. Safety and effectiveness have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, discuss with your doctor the benefits and risks of using Exelderm Solution during pregnancy. It is unknown if Exelderm Solution is excreted in breast milk. If you are or will be breast-feeding while you are using Exelderm Solution, check with your doctor or pharmacist to discuss the risks to your baby.


Possible side effects of Exelderm Solution:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Burning; itching; redness; stinging.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Exelderm side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of Exelderm Solution:

Store Exelderm Solution at room temperature. Avoid temperatures above 104 degrees F (40 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Exelderm Solution out of the reach of children and away from pets.


General information:


  • If you have any questions about Exelderm Solution, please talk with your doctor, pharmacist, or other health care provider.

  • Exelderm Solution is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Exelderm Solution. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Exelderm resources


  • Exelderm Side Effects (in more detail)
  • Exelderm Use in Pregnancy & Breastfeeding
  • Exelderm Support Group
  • 0 Reviews for Exelderm - Add your own review/rating


Compare Exelderm with other medications


  • Impetigo
  • Tinea Corporis
  • Tinea Cruris
  • Tinea Pedis
  • Tinea Versicolor

Ergocalciferol




VITAMIN D (Ergocalciferol Capsules, USP) 1.25 mg (50,000 USP Units)

Ergocalciferol Description



Ergocalciferol Capsules, USP, are a synthetic calcium regulator for oral administration.


Ergocalciferol is a white, colorless crystal, insoluble in water, soluble in organic solvents, and slightly soluble in vegetable oils.


It is affected by air and by light. Ergosterol or provitamin D2 is found in plants and yeast and has no antirachitic activity.


There are more than 10 substances belonging to a group of steroid compounds, classified as having vitamin D or antirachitic activity.


One USP unit of vitamin D2 is equivalent to one International Unit (IU), and 1 mcg of vitamin D2 is equal to 40 IU.


Each capsule contains 1.25 mg (50,000 International Units vitamin D) of Ergocalciferol, USP, in an edible vegetable oil.


Ergocalciferol, also called vitamin D2, is 9, 10-secoergosta-5, 7, 10 (19), 22-tetraen-3-ol,(3β,5Z,7E,22E)-; (C28H44O) with a molecular weight of 396.65, and has the following structural formula:







Inactive Ingredients:




Each capsule contains soybean oil.  The capsule shell and/or band contains FD&C Blue No. 1, D&C Yellow No. 10, Sodium Lauryl Sulfate, Gelatin, Polysorbate 80, Benzyl Alcohol, Methylparaben, Butylparaben and Propylparaben.

Ergocalciferol - Clinical Pharmacology


The in vivo synthesis of the major biologically active metabolites of vitamin D occurs in two steps. The first hydroxylation of Ergocalciferol takes place in the liver (to 25-hydroxyvitamin D) and the second in the kidneys (to 1,25-dihydroxyvitamin D). Vitamin D metabolites promote the active absorption of calcium and phosphorus by the small intestine, thus elevating serum calcium and phosphate levels sufficiently to permit bone mineralization. Vitamin D metabolites also mobilize calcium and phosphate from bone and probably increase the reabsorption of calcium and perhaps also of phosphate by the renal tubules.


There is a time lag of 10 to 24 hours between the administration of vitamin D and the initiation of its action in the body due to the necessity of synthesis of the active metabolites in the liver and kidneys. Parathyroid hormone is responsible for the regulation of this metabolism in the kidneys.



INDICATIONS & USAGE




Ergocalciferol capsules are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.

Contraindications




Ergocalciferol capsules are contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin D, and hypervitaminosis D.

Warnings



Hypersensitivity to vitamin D may be one etiologic factor in infants with idiopathic hypercalcemia. In these cases vitamin D must be strictly restricted.

Keep out of the reach of children.



Precautions




General


Vitamin D administration from fortified foods, dietary supplements, self-administered and prescription drug sources should be evaluated. Therapeutic dosage should be readjusted as soon as there is clinical improvement. Dosage levels must be individualized and great care exercised to prevent serious toxic effects. IN VITAMIN D RESISTANT RICKETS THE RANGE BETWEEN THERAPEUTIC AND TOXIC DOSES IS NARROW. When high therapeutic doses are used progress should be followed with frequent blood calcium determinations. In the treatment of hypoparathyroidism, intravenous calcium, parathyroid hormone, and/or dihydrotachysterol may be required.


Maintenance of a normal serum phosphorus level by dietary phosphate restriction and/or administration of aluminum gels as intestinal phosphate binders in those patients with hyperphosphatemia as frequently seen in renal osteodystrophy is essential to prevent metastatic calcification. Adequate dietary calcium is necessary for clinical response to vitamin D therapy.


Protect from light.



Drug Interactions


Mineral oil interferes with the absorption of fat-soluble vitamins, including vitamin D preparations. Administration of thiazide diuretics to hypoparathyroid patients who are concurrently being treated with Ergocalciferol capsules may cause hypercalcemia.



Carcinogenesis, Mutagenesis, Impairment of Fertility


No long-term animal studies have been performed to evaluate the drug's potential in these areas.



Pregnancy Category C


Animal reproduction studies have shown fetal abnormalities in several species associated with hypervitaminosis D. These are similar to the supravalvular aortic stenosis syndrome described in infants by Black in England (1963). This syndrome was characterized by supravalvular aortic stenosis, elfin facies, and mental retardation. For the protection of the fetus, therefore, the use of vitamin D in excess of the recommended dietary allowance during normal pregnancy should be avoided unless, in the judgment of the physician, potential benefits in a specific, unique case outweigh the significant hazards involved. The safety in excess of 400 USP Units of vitamin D daily during pregnancy has not been established.



Nursing Mothers


Caution should be exercised when Ergocalciferol capsules are administered to a nursing woman. In a mother given large doses of vitamin D, 25-hydroxycholecalciferol appeared in the milk and caused hypercalcemia in her child. Monitoring of the infant's serum calcium concentration is required in that case (Goldberg, 1972).



Pediatric Use


Pediatric doses must be individualized (see DOSAGE & ADMINISTRATION).



Geriatric Use


Clinical studies of Ergocalciferol capsules did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. A few published reports have suggested that the absorption of orally administered vitamin D may be attenuated in elderly compared to younger, individuals. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.



Adverse Reactions




Hypervitaminosis D is characterized by effects on the following organ system:

Renal: Impairment of renal function with polyuria, nocturia, polydipsia, hypercalciuria, reversible azotemia, hypertension, nephrocalcinosis, generalized vascular calcification, or irreversible renal insufficiency which may result in death.


CNS: Mental retardation.


Soft Tissues: Widespread calcification of the soft tissues, including the heart, blood vessels, renal tubules, and lungs.


Skeletal: Bone demineralization (osteoporosis) in adults occurs concomitantly. Decline in the average rate of linear growth and increased mineralization of bones in infants and children (dwarfism) vague aches, stiffness, and weakness.


Gastrointestinal: Nausea, anorexia, constipation.


Metabolic: Mild acidosis, anemia, weight loss.



Overdosage



The effects of administered vitamin D can persist for two or more months after cessation of treatment.


Hypervitaminosis D is characterized by:


  1. Hypercalcemia with anorexia, nausea, weakness, weight loss, vague aches and stiffness, constipation, mental retardation, anemia, and mild acidosis.

  2. Impairment of renal function with polyuria, nocturia, polydipsia, hypercalciuria, reversible azotemia, hypertension, nephrocalcinosis, generalized vascular calcification, or irreversible renal insufficiency which may result in death.

  3. Widespread calcification of the soft tissues, including the heart, blood vessels, renal tubules, and lungs. Bone demineralization (osteoporosis) in adults occurs concomitantly.

  4. Decline in the average rate of linear growth and increased mineralization of bones in infants and children (dwarfism).

The treatment of hypervitaminosis D with hypercalcemia consists of immediate withdrawal of the vitamin, a low calcium diet, generous intake of fluids, along with symptomatic and supportive treatment. Hypercalcemic crisis with dehydration, stupor, coma, and azotemia requires more vigorous treatment. The first step should be hydration of the patient. Intravenous saline may quickly and significantly increase urinary calcium excretion. A loop diuretic (furosemide or ethacrynic acid) may be given with the saline infusion to further increase renal calcium excretion. Other reported therapeutic measures include dialysis or the administration of citrates, sulfates, phosphates, corticosteroids, EDTA (ethylenediaminetetraacetic acid), and mithramycin via appropriate regimens. With appropriate therapy, recovery is the usual outcome when no permanent damage has occurred. Deaths via renal or cardiovascular failure have been reported.


The LD50 in animals is unknown. The toxic oral dose of Ergocalciferol in the dog is 4 mg/kg.




DOSAGE & ADMINISTRATION




THE RANGE BETWEEN THERAPEUTIC AND TOXIC DOSES IS NARROW.


Vitamin D Resistant Rickets:

12,000 to 500,000 USP Units daily.


Hypoparathyroidism:

50,000 to 200,000 USP Units daily concomitantly with calcium lactate 4 g, six times per day.


DOSAGE MUST BE INDIVIDUALIZED UNDER CLOSE MEDICAL SUPERVISION.


Calcium intake should be adequate. Blood calcium and phosphorus determinations must be made every 2 weeks or more frequently if necessary. X-rays of the bones should be taken every month until condition is corrected and stabilized.



How is Ergocalciferol Supplied



Capsules of 1.25 mg (50,000 USP Units vitamin D) of Ergocalciferol, USP are transparent green banded capsules, imprinted with “Σ 6” on the cap and body.


Bottles of 100 capsules (NDC 42794-006-02).


Store at 20° - 25° C (68° - 77° F); excursions permitted between 15° - 30°C (59° - 86°F) [see USP Controlled Room Temperature].




Manufactured by:

Sigmapharm Laboratories, LLC

Bensalem, PA 19020


Rx only


OS006-04 REV.0311



PRINCIPAL DISPLAY PANEL





NDC 42794-006-02      100 Capsules


Vitamin D

(Ergocalciferol Capsules, USP)


1.25 mg*


(50,000 USP Units)


*Each capsule contains Vitamin D (Ergocalciferol)


1.25 mg equivalent to 50,000 USP units


Rx Only










Ergocalciferol 
Ergocalciferol  capsule, liquid filled










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)42794-006
Route of AdministrationORALDEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Ergocalciferol (Ergocalciferol)Ergocalciferol1.25 mg
























Inactive Ingredients
Ingredient NameStrength
soybean oil 
gelatin 
D&C Yellow No. 10 
FD&C Blue No. 1 
Polysorbate 80 
Benzyl Alcohol 
Methylparaben 
Butylparaben 
Propylparaben 
Sodium Lauryl Sulfate 


















Product Characteristics
ColorgreenScoreno score
ShapeCAPSULESize18mm
FlavorImprint Code6
Contains      










Packaging
#NDCPackage DescriptionMultilevel Packaging
142794-006-02100 CAPSULE In 1 BOTTLENone










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA09100401/28/2012


Labeler - SigmaPharm Laboratories, LLC (556234636)

Registrant - SigmaPharm Laboratories, LLC (556234636)









Establishment
NameAddressID/FEIOperations
SigmaPharm Laboratories, LLC556234636analysis, manufacture
Revised: 01/2012SigmaPharm Laboratories, LLC